LON:APH Alliance Pharma (APH) Share Price, News & Analysis GBX 64.70 0.00 (0.00%) As of 05/14/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesBuy This Stock About Alliance Pharma Stock (LON:APH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alliance Pharma alerts:Sign Up Key Stats Today's Range 64.70▼ 64.7050-Day Range 64.70▼ 64.7052-Week Range 30.50▼ 66.20VolumeN/AAverage Volume5.95 million shsMarket Capitalization£350.31 millionP/E RatioN/ADividend Yield3.09%Price TargetGBX 6,250Consensus RatingHold Company Overview Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. Read More Alliance Pharma Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreAPH MarketRank™: Alliance Pharma scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingAlliance Pharma has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAlliance Pharma has received no research coverage in the past 90 days.Read more about Alliance Pharma's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Alliance Pharma is -10.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alliance Pharma is -10.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAlliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioAlliance Pharma has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for APH. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipAlliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAlliance Pharma does not have a long track record of dividend growth.Read more about Alliance Pharma's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for APH. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 29 people have searched for APH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alliance Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders11.95% of the stock of Alliance Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.34% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alliance Pharma's insider trading history. Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APH Stock News HeadlinesRBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)March 11, 2025 | markets.businessinsider.comAlliance Pharma Valued at $468 Million Under Increased Offer From Aegros BidcoMarch 10, 2025 | marketwatch.com“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 28 at 2:00 AM | Weiss Ratings (Ad)Alliance Pharma agrees £362m takeover by biggest shareholderMarch 10, 2025 | msn.comUK's Alliance Pharma agrees to final cash offer from asset management firm DBAYMarch 10, 2025 | reuters.comAlliance Pharma And 2 Other UK Penny Stocks With Promising FundamentalsFebruary 27, 2025 | finance.yahoo.comAlliance Pharma Expected Revenue Falls on Consumer Healthcare DeclineJanuary 31, 2025 | marketwatch.comAlliance Pharma Regulatory NewsJanuary 31, 2025 | lse.co.ukSee More Headlines APH Stock Analysis - Frequently Asked Questions How have APH shares performed this year? Alliance Pharma's stock was trading at GBX 45.55 at the start of the year. Since then, APH shares have increased by 42.0% and is now trading at GBX 64.70. How were Alliance Pharma's earnings last quarter? Alliance Pharma plc (LON:APH) issued its earnings results on Tuesday, April, 8th. The company reported $4.32 EPS for the quarter. Alliance Pharma had a negative trailing twelve-month return on equity of 15.24% and a negative net margin of 18.34%. How do I buy shares of Alliance Pharma? Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM). Company Calendar Last Earnings4/08/2025Today8/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryElectronic Equipment Current SymbolLON:APH CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees91,000Year FoundedN/APrice Target and Rating Average Price Target for Alliance PharmaGBX 6,250 High Price TargetGBX 6,250 Low Price TargetGBX 6,250 Potential Upside/Downside+9,560.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX (6.20) Trailing P/E RatioN/A Forward P/E Ratio12.47 P/E Growth1.04Net Income-£33.65 million Net Margins-18.34% Pretax MarginN/A Return on Equity-15.24% Return on Assets5.98% Debt Debt-to-Equity Ratio46.27 Current Ratio2.93 Quick Ratio1.42 Sales & Book Value Annual Sales£183.50 million Price / Sales1.91 Cash FlowGBX 8.22 per share Price / Cash Flow7.87 Book ValueGBX 41.25 per share Price / Book1.57Miscellaneous Outstanding Shares541,444,969Free FloatN/AMarket Cap£350.31 million OptionableNot Optionable Beta0.67 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (LON:APH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alliance Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.